Global Biologics and Biosimilars Market Survey and Trend Research 2018
Summary
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 Biologics and Biosimilars Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 BIOLOGICS AND BIOSIMILARS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Roche (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Amgen (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 AbbVie (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Sanofi-Aventis (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Pfizer (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Pfizer (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Novo Nordisk (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Eli Lilly (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Novartis (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Merck (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 3sbio (Company Overview, Sales Data etc.)
4.12 Changchun High Tech (Company Overview, Sales Data etc.)
4.13 CP Guojian (Company Overview, Sales Data etc.)
4.14 Biotech (Company Overview, Sales Data etc.)
4.15 Gelgen (Company Overview, Sales Data etc.)
4.16 Innovent (Company Overview, Sales Data etc.)
4.17 Dong Bao (Company Overview, Sales Data etc.)
4.18 Ganlee (Company Overview, Sales Data etc.)
4.19 United Laboratories (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 Biologics and Biosimilars Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 BIOLOGICS AND BIOSIMILARS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Roche (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Amgen (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 AbbVie (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Sanofi-Aventis (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Pfizer (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Pfizer (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Novo Nordisk (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Eli Lilly (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Novartis (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Merck (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 3sbio (Company Overview, Sales Data etc.)
4.12 Changchun High Tech (Company Overview, Sales Data etc.)
4.13 CP Guojian (Company Overview, Sales Data etc.)
4.14 Biotech (Company Overview, Sales Data etc.)
4.15 Gelgen (Company Overview, Sales Data etc.)
4.16 Innovent (Company Overview, Sales Data etc.)
4.17 Dong Bao (Company Overview, Sales Data etc.)
4.18 Ganlee (Company Overview, Sales Data etc.)
4.19 United Laboratories (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table GLOBAL BIOLOGICS AND BIOSIMILARS MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Biologics and Biosimilars Market 2012-2017, by Type, in Volume
Table Global Biologics and Biosimilars Market Forecast 2018-2023, by Type, in USD Million
Table Global Biologics and Biosimilars Market Forecast 2018-2023, by Type, in Volume
Table Roche Overview List
Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 3sbio Overview List
Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Changchun High Tech Overview List
Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CP Guojian Overview List
Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biotech Overview List
Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gelgen Overview List
Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Innovent Overview List
Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dong Bao Overview List
Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ganlee Overview List
Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Laboratories Overview List
Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Biologics and Biosimilars Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Biologics and Biosimilars Sales Revenue Share, by Companies, in USD Million
Table Global Biologics and Biosimilars Sales Volume 2012-2017, by Companies, in Volume
Table Global Biologics and Biosimilars Sales Revenue Share, by Companies in 2017, in Volume
Table Biologics and Biosimilars Demand 2012-2017, by Application, in USD Million
Table Biologics and Biosimilars Demand 2012-2017, by Application, in Volume
Table Biologics and Biosimilars Demand Forecast 2018-2023, by Application, in USD Million
Table Biologics and Biosimilars Demand Forecast 2018-2023, by Application, in Volume
Table Global Biologics and Biosimilars Market 2012-2017, by Region, in USD Million
Table Global Biologics and Biosimilars Market 2012-2017, by Region, in Volume
Table Biologics and Biosimilars Market Forecast 2018-2023, by Region, in USD Million
Table Biologics and Biosimilars Market Forecast 2018-2023, by Region, in Volume
Table GLOBAL BIOLOGICS AND BIOSIMILARS MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Biologics and Biosimilars Market 2012-2017, by Type, in Volume
Table Global Biologics and Biosimilars Market Forecast 2018-2023, by Type, in USD Million
Table Global Biologics and Biosimilars Market Forecast 2018-2023, by Type, in Volume
Table Roche Overview List
Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 3sbio Overview List
Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Changchun High Tech Overview List
Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CP Guojian Overview List
Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biotech Overview List
Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gelgen Overview List
Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Innovent Overview List
Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dong Bao Overview List
Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ganlee Overview List
Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Laboratories Overview List
Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Biologics and Biosimilars Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Biologics and Biosimilars Sales Revenue Share, by Companies, in USD Million
Table Global Biologics and Biosimilars Sales Volume 2012-2017, by Companies, in Volume
Table Global Biologics and Biosimilars Sales Revenue Share, by Companies in 2017, in Volume
Table Biologics and Biosimilars Demand 2012-2017, by Application, in USD Million
Table Biologics and Biosimilars Demand 2012-2017, by Application, in Volume
Table Biologics and Biosimilars Demand Forecast 2018-2023, by Application, in USD Million
Table Biologics and Biosimilars Demand Forecast 2018-2023, by Application, in Volume
Table Global Biologics and Biosimilars Market 2012-2017, by Region, in USD Million
Table Global Biologics and Biosimilars Market 2012-2017, by Region, in Volume
Table Biologics and Biosimilars Market Forecast 2018-2023, by Region, in USD Million
Table Biologics and Biosimilars Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Biologics and Biosimilars Industry Chain Structure
Figure Global Biologics and Biosimilars Market Growth 2012-2017, by Type, in USD Million
Figure Global Biologics and Biosimilars Market Growth 2012-2017, by Type, in Volume
Figure Global Biologics and Biosimilars Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Biologics and Biosimilars Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Biologics and Biosimilars Industry Chain Structure
Figure Global Biologics and Biosimilars Market Growth 2012-2017, by Type, in USD Million
Figure Global Biologics and Biosimilars Market Growth 2012-2017, by Type, in Volume
Figure Global Biologics and Biosimilars Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Biologics and Biosimilars Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
